Skip to main content

Table 3 Treatments before and after first consultation with diagnosis of interest

From: The course of primary progressive aphasia diagnosis: a cross-sectional study

 

Before first consultation with diagnosis of interest

After first consultation with diagnosis of interest

 

n

(%)

n

(%)

p-value

PPA patients

Pharmacological treatments

  Antidepressant

330

(20.4)

629

(38.8)

<.001

  Anxiolytic

130

(8.0)

237

(14.6)

<.001

  Hypnotic

64

(4.0)

94

(5.8)

<.001

  Neuroleptic

29

(1.8)

116

(7.2)

<.001

  NMDA antagonist

77

(4.8)

306

(18.9)

<.001

  ChEI

144

(8.9)

426

(26.3)

<.001

Non-pharmacological treatments

  Day hospital

24

(1.5)

158

(9.8)

<.001

  Speech and language therapist (SLT)

365

(22.7)

1060

(66.0)

<.001

  Psychologist

66

(4.1)

130

(8.1)

<.001

  Kinesiologist

35

(2.2)

169

(10.5)

<.001

  Occupational therapist

17

(1.1)

50

(3.1)

<.001

  Stakeholder group

24

(1.5)

84

(5.2)

<.001

AD patients

Pharmacological treatments

  Antidepressant

10,261

(24.1)

16,528

(38.8)

<.001

  Anxiolytic

5226

(12.3)

8626

(20.3)

<.001

  Hypnotic

2375

(5.6)

3380

(7.9)

<.001

  Neuroleptic

1359

(3.2)

3943

(9.3)

<.001

  NMDA antagonist

1801

(4.2)

11,670

(27.4)

<.001

  ChEI

5967

(14.0)

24,927

(58.6)

<.001

Non-pharmacological treatments

  Day hospital

628

(1.5)

5272

(12.7)

<.001

  Speech and language therapist (SLT)

2,785

(6.7)

8807

(21.2)

<.001

  Psychologist

1214

(2.9)

2377

(5.7)

<.001

  Kinesiologist

1562

(3.8)

4311

(10.4)

<.001

  Occupational therapist

658

(1.6)

1546

(3.7)

<.001

  Stakeholder group

941

(2.3)

3038

(7.3)

<.001

  1. *McNemar test